A new soy germ fermented ingredient displays estrogenic and protease inhibitor activities able to prevent irritable bowel syndrome-like symptoms in stressed female rats

Clinical Nutrition

Volumn 32, Issue 1, 2013, Pages 51-58

  Moussa, Lara ^a,b   Bézirard, Valérie ^a   Salvador Cartier, Christel ^a   Bacquié, Valérie ^a   Houdeau, Eric ^a   Théodorou, Vassilia ^a  

^a TOXALIM RESEARCH CENTRE IN FOOD TOXICOLOGY   (France)

^b GENIBIO ^*  (France)

Author keywords

Acute stress; Estradiol; Intestinal paracellular permeability; Soy; Visceral pain

Indexed keywords

CORTICOSTERONE; ESTRADIOL BENZOATE; MAST CELL PROTEASE II; OCCLUDIN; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ACUTE STRESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; FEMALE; FERMENTED PRODUCT; INTESTINE MUCOSA PERMEABILITY; IRRITABLE COLON; MAST CELL; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; SOY GERM FERMENTED INGREDIENT; THERAPY EFFECT; VISCERAL PAIN;

ANIMALS; DISEASE MODELS, ANIMAL; ESTRADIOL; ESTROGEN RECEPTOR MODULATORS; FECES; FEMALE; FERMENTATION; GASTROINTESTINAL TRACT; GERMINATION; IRRITABLE BOWEL SYNDROME; PERMEABILITY; PHYTOESTROGENS; PROTEASE INHIBITORS; PROTEOLYSIS; RATS; RATS, WISTAR; RECEPTORS, ESTROGEN; SEEDS; SOY FOODS; SOYBEANS; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL;

EID: 84872602268     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2012.05.021     Document Type: Article

References (50)

1. Longstreth G.F. Definition and classification of irritable bowel syndrome: current consensus and controversies. Gastroenterol Clin North Am 2005, 34:173-187.
2. Thompson W.G., Longstreth G.F., Drossman D.A., Heaton K.W., Irvine E.J., Muller-Lissner S.A. Functional bowel disorders and functional abdominal pain. Gut 1999, 45(Suppl. 2):II43-II47.
3. Ritchie J. Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome. Gut 1973, 14:125-132.
4. Spiller R.C., Jenkins D., Thornley J.P., Hebden J.M., Wright T., Skinner M., et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000, 47:804-811.
5. Osterberg E., Blomquist L., Krakau I., Weinryb R.M., Asberg M., Hultcrantz R. A population study on irritable bowel syndrome and mental health. Scand J Gastroenterol 2000, 35:264-268.
6. Thompson W.G., Heaton K.W., Smyth G.T., Smyth C. Irritable bowel syndrome in general practice: prevalence, characteristics, and referral. Gut 2000, 46:78-82.
7. Smith Y.R., Stohler C.S., Nichols T.E., Bueller J.A., Koeppe R.A., Zubieta J.K. Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women. J Neurosci 2006, 26:5777-5785.
8. Houghton L.A., Lea R., Jackson N., Whorwell P.J. The menstrual cycle affects rectal sensitivity in patients with irritable bowel syndrome but not healthy volunteers. Gut 2002, 50:471-474.
9. Ait-Belgnaoui A., Bradesi S., Fioramonti J., Theodorou V., Bueno L. Acute stress-induced hypersensitivity to colonic distension depends upon increase in paracellular permeability: role of myosin light chain kinase. Pain 2005, 113:141-147.
10. Braniste V., Leveque M., Buisson-Brenac C., Bueno L., Fioramonti J., Houdeau E. Oestradiol decreases colonic permeability through oestrogen receptor beta-mediated up-regulation of occludin and junctional adhesion molecule-A in epithelial cells. J Physiol 2009, 587:3317-3328.
11. Zhou Q., Zhang B., Verne G.N. Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome. Pain 2009, 146:41-46.
12. Chang L., Sundaresh S., Elliott J., Anton P.A., Baldi P., Licudine A., et al. Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome. Neurogastroenterol Motil 2009, 21:149-159.
13. Cenac N., Andrews C.N., Holzhausen M., Chapman K., Cottrell G., Andrade-Gordon P., et al. Role for protease activity in visceral pain in irritable bowel syndrome. J Clin Invest 2007, 117:636-647.
14. Roka R., Rosztoczy A., Leveque M., Izbeki F., Nagy F., Molnar T., et al. A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol 2007, 5:550-555.
15. Gecse K., Roka R., Ferrier L., Leveque M., Eutamene H., Cartier C., et al. Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity. Gut 2008, 57:591-599.
16. Weston A.P., Biddle W.L., Bhatia P.S., Miner P.B. Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci 1993, 38:1590-1595.
17. Coelho A.M., Fioramonti J., Bueno L. Mast cell degranulation induces delayed rectal allodynia in rats: role of histamine and 5-HT. Dig Dis Sci 1998, 43:727-737.
18. Wada-Hiraike O., Imamov O., Hiraike H., Hultenby K., Schwend T., Omoto Y., et al. Role of estrogen receptor beta in colonic epithelium. Proc Natl Acad Sci U S A 2006, 103:2959-2964.
19. Hubert J., Berger M., Nepveu F., Paul F., Daydé J. Effects of fermentation on the phytochemical composition and antioxidant properties of soy germ. Food Chem 2008, 109:709-721.
20. Setchell K.D., Brown N.M., Zimmer-Nechemias L., Brashear W.T., Wolfe B.E., Kirschner A.S., et al. Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability. Am J Clin Nutr 2002, 76:447-453.
21. Morito K., Hirose T., Kinjo J., Hirakawa T., Okawa M., Nohara T., et al. Interaction of phytoestrogens with estrogen receptors alpha and beta. Biol Pharm Bull 2001, 24:351-356.
22. Birk Y. The Bowman-Birk inhibitor. Trypsin- and chymotrypsin-inhibitor from soybeans. Int J Pept Protein Res 1985, 25:113-131.
23. Lichtenstein G.R., Deren J.J., Katz S., Lewis J.D., Kennedy A.R., Ware J.H. Bowman-Birk inhibitor concentrate: a novel therapeutic agent for patients with active ulcerative colitis. Dig Dis Sci 2008, 53:175-180.
24. Kennedy A.R., Szuhaj B.F., Newberne P.M., Billings P.C. Preparation and production of a cancer chemopreventive agent, Bowman-Birk inhibitor concentrate. Nutr Cancer 1993, 19:281-302.
25. Schryver T. Increasing health benefits using soy germ. Cereal Food World 2002, 47:185-188.
26. Morteau O., Hachet T., Caussette M., Bueno L. Experimental colitis alters visceromotor response to colorectal distension in awake rats. Dig Dis Sci 1994, 39:1239-1248.
27. Williams C.L., Peterson J.M., Villar R.G., Burks T.F. Corticotropin-releasing factor directly mediates colonic responses to stress. Am J Physiol 1987, 253:G582-G586.
28. Ait-Belgnaoui A., Han W., Lamine F., Eutamene H., Fioramonti J., Bueno L., et al. Lactobacillus farciminis treatment suppresses stress induced visceral hypersensitivity: a possible action through interaction with epithelial cell cytoskeleton contraction. Gut 2006, 55:1090-1094.
29. Bradesi S., Eutamene H., Garcia-Villar R., Fioramonti J., Bueno L. Acute and chronic stress differently affect visceral sensitivity to rectal distension in female rats. Neurogastroenterol Motil 2002, 14:75-82.
30. Bjarnason I., MacPherson A., Hollander D. Intestinal permeability: an overview. Gastroenterology 1995, 108:1566-1581.
31. Heitkemper M.M., Cain K.C., Jarrett M.E., Burr R.L., Hertig V., Bond E.F. Symptoms across the menstrual cycle in women with irritable bowel syndrome. Am J Gastroenterol 2003, 98:420-430.
32. Drossman D.A., Ringel Y., Vogt B.A., Leserman J., Lin W., Smith J.K., et al. Alterations of brain activity associated with resolution of emotional distress and pain in a case of severe irritable bowel syndrome. Gastroenterology 2003, 124:754-761.
33. Konstantinopoulos P.A., Kominea A., Vandoros G., Sykiotis G.P., Andricopoulos P., Varakis I., et al. Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. Eur J Cancer 2003, 39:1251-1258.
34. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998, 139:4252-4263.
35. Drossman D.A., McKee D.C., Sandler R.S., Mitchell C.M., Cramer E.M., Lowman B.C., et al. Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology 1988, 95:701-708.
36. Whitehead W.E., Bosmajian L., Zonderman A.B., Costa P.T., Schuster M.M. Symptoms of psychologic distress associated with irritable bowel syndrome. Comparison of community and medical clinic samples. Gastroenterology 1988, 95:709-714.
37. Ji Y., Murphy A.Z., Traub R.J. Estrogen modulates the visceromotor reflex and responses of spinal dorsal horn neurons to colorectal stimulation in the rat. J Neurosci 2003, 23:3908-3915.
38. Kawakita S., Marotta F., Naito Y., Gumaste U., Jain S., Tsuchiya J., et al. Effect of an isoflavones-containing red clover preparation and alkaline supplementation on bone metabolism in ovariectomized rats. Clin Interv Aging 2009, 4:91-100.
39. Adlercreutz H., Mazur W. Phyto-oestrogens and western diseases. Ann Med 1997, 29:95-120.
40. Weber K.S., Setchell K.D., Stocco D.M., Lephart E.D. Dietary soy-phytoestrogens decrease testosterone levels and prostate weight without altering LH, prostate 5alpha-reductase or testicular steroidogenic acute regulatory peptide levels in adult male Sprague-Dawley rats. J Endocrinol 2001, 170:591-599.
41. Barreau F., Ferrier L., Fioramonti J., Bueno L. Neonatal maternal deprivation triggers long term alterations in colonic epithelial barrier and mucosal immunity in rats. Gut 2004, 53:501-506.
42. Gareau M.G., Jury J., Perdue M.H. Neonatal maternal separation of rat pups results in abnormal cholinergic regulation of epithelial permeability. Am J Physiol Gastrointest Liver Physiol 2007, 293:G198-G203.
43. Castagliuolo I., Lamont J.T., Qiu B., Fleming S.M., Bhaskar K.R., Nikulasson S.T., et al. Acute stress causes mucin release from rat colon: role of corticotropin releasing factor and mast cells. Am J Physiol 1996, 271:G884-G892.
44. Eutamene H., Theodorou V., Fioramonti J., Bueno L. Acute stress modulates the histamine content of mast cells in the gastrointestinal tract through interleukin-1 and corticotropin-releasing factor release in rats. J Physiol 2003, 553:959-966.
45. Alexandrakis M.G., Kyriakou D.S., Kempuraj D., Huang M., Boucher W., Seretakis D., et al. The isoflavone genistein inhibits proliferation and increases histamine content in human leukemic mast cells. Allergy Asthma Proc 2003, 24:373-377.
46. Bandara M., Arun S.J., Allanson M., Widyarini S., Chai Z., Reeve V.E. Topical isoflavonoids reduce experimental cutaneous inflammation in mice. Immunol Cell Biol 2010, 88:727-733.
47. Setchell K.D., Brown N.M., Desai P., Zimmer-Nechemias L., Wolfe B.E., Brashear W.T., et al. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr 2001, 131:1362S-1375S.
48. Billings P.C., St Clair W.H., Maki P.A., Kennedy A.R. Distribution of the Bowman Birk protease inhibitor in mice following oral administration. Cancer Lett 1992, 62:191-197.
49. Hawkins J.V., Emmel E.L., Feuer J.J., Nedelman M.A., Harvey C.J., Klein H.J., et al. Protease activity in a hapten-induced model of ulcerative colitis in rats. Dig Dis Sci 1997, 42:1969-1980.
50. Demaude J., Leveque M., Chaumaz G., Eutamene H., Fioramonti J., Bueno L., et al. Acute stress increases colonic paracellular permeability in mice through a mast cell-independent mechanism: involvement of pancreatic trypsin. Life Sci 2009, 84:847-852.